Intermittent ibrutinib in chronic lymphocytic leukemia

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-508638-32-00

Enrollment

Registered

2023-11-08

Start date

2018-04-06

Completion date

Unknown

Last updated

2023-11-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic lymphocytic leukemia

None listed

Sex/Gender

All

Age

18 Years to No maximum

Norway, Sweden

None listed

Source: EU CTIS · Data processed: Feb 4, 2026